Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpwin Grp Regulatory News (EPWN)

  • This share is currently suspended. It was suspended at a price of 119.50
  • There is currently no data for EPWN

Trading Statement

8 Feb 2018 07:00

RNS Number : 2485E
Epwin Group PLC
08 February 2018
 

8 February 2018

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Epwin Group Plc

("Epwin" or the "Group")

 

Year-end trading update and notice of results

 

Epwin Group Plc, the low maintenance building products manufacturer, supplying businesses in the Repair, Maintenance and Improvement ("RMI"), new build and social housing sectors, announces its trading update in respect of the year ended 31 December 2017 and notice of its full year results.

 

Trading update

 

The Group's operating profits, before non-underlying items, for the year ended 31 December 2017 are expected to be in line with market expectations. Net debt at the year-end is also expected to be in line with market expectations, with leverage at less than 1x underlying EBITDA.

 

The Group's performance has been resilient, despite the previously reported issues affecting the Group's two largest customers and the input cost inflation experienced during the year. The Group has continued to deliver on its strategy, particularly noting the strong sales of the Profile 22 Optima window profile system and WPC decking products.

 

Our programme of operational improvement continues, having completed the consolidation of our glass production facilities onto one site and the phased consolidation of two further production units onto one site is progressing well. In addition, we continue to develop our logistics capabilities at the Scunthorpe site with new warehousing.

 

We expect market conditions to remain challenging in the near term and anticipate that the RMI market will continue to be subdued in 2018. Despite this, we expect to make further progress with our strategy focussed on operational improvement, broadening the product portfolio, selective acquisitions, cross selling and market share growth in key sectors to build a platform for future growth.

 

Notice of results

The Group will announce its full year results for the year ended 31 December 2017 on 11 April 2018.

Jon Bednall, CEO of Epwin, commented:

"Epwin delivered a resilient performance in 2017, despite the issues affecting the Group's two largest customers and the significant increases in input costs. In the second half of the year we progressed with our strategy of broadening our product portfolio and channels to market, as well as continuing our programme of operational efficiency improvements through further site consolidation. We remain confident in the long term drivers in the RMI market and continuing our record of strong cash generation."

 

 

Contact information

 

Epwin Group Plc

Jon Bednall, Chief Executive

Chris Empson, Group Finance Director

 

0203 128 8100

Zeus Capital Limited (Nomad and Joint Broker)

Nick Cowles / Jamie Peel

John Goold / Dominic King

 

Panmure Gordon (UK) Limited (Joint Broker)

Erik Anderson / Andrew Potts

 

0161 831 1512

0203 829 5000

 

 

0207 886 2500

 

MHP Communications

Reg Hoare / Charlie Barker

 

 

0203 128 8100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKODKCBKDPBK
Date   Source Headline
4th Mar 20255:10 pmRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSTransaction in Own Shares
28th Feb 20255:23 pmRNSTransaction in Own Shares
27th Feb 20255:14 pmRNSTransaction in Own Shares
27th Feb 20254:06 pmRNSHolding(s) in Company
26th Feb 20255:54 pmRNSTransaction in Own Shares
25th Feb 20256:05 pmRNSTransaction in Own Shares
24th Feb 20254:23 pmRNSTransaction in Own Shares
21st Feb 20254:58 pmRNSTransaction in Own Shares
20th Feb 20255:09 pmRNSTransaction in Own Shares
19th Feb 20255:09 pmRNSTransaction in Own Shares
18th Feb 20255:21 pmRNSTransaction in Own Shares
17th Feb 20255:22 pmRNSTransaction in Own Shares
17th Feb 20257:00 amRNSDirector/PDMR Shareholding
14th Feb 20254:26 pmRNSTransaction in Own Shares
13th Feb 20255:39 pmRNSTransaction in Own Shares
12th Feb 20255:21 pmRNSTransaction in Own Shares
11th Feb 20255:01 pmRNSTransaction in Own Shares
10th Feb 20254:54 pmRNSTransaction in Own Shares
7th Feb 20255:41 pmRNSTransaction in Own Shares
6th Feb 20255:03 pmRNSTransaction in Own Shares
5th Feb 20255:30 pmRNSTransaction in Own Shares
4th Feb 20255:16 pmRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20254:43 pmRNSTransaction in Own Shares
30th Jan 20253:53 pmRNSTransaction in Own Shares
29th Jan 20254:38 pmRNSTransaction in Own Shares
28th Jan 20255:01 pmRNSTransaction in Own Shares
24th Jan 20254:53 pmRNSTransaction in Own Shares
23rd Jan 20254:43 pmRNSTransaction in Own Shares
22nd Jan 20254:52 pmRNSTransaction in Own Shares
21st Jan 20255:12 pmRNSTransaction in Own Shares
21st Jan 20257:00 amRNSYear-end trading update and notice of results
20th Jan 20255:05 pmRNSTransaction in Own Shares
17th Jan 20255:27 pmRNSTransaction in Own Shares
16th Jan 20254:40 pmRNSTransaction in Own Shares
15th Jan 20255:17 pmRNSTransaction in Own Shares
14th Jan 20255:35 pmRNSTransaction in Own Shares
13th Jan 20254:52 pmRNSTransaction in Own Shares
13th Jan 20257:00 amRNSBlock listing Interim Review
10th Jan 20255:27 pmRNSTransaction in Own Shares
9th Jan 20255:26 pmRNSTransaction in Own Shares
8th Jan 20255:45 pmRNSTransaction in Own Shares
7th Jan 20254:38 pmRNSTransaction in Own Shares
2nd Jan 20256:17 pmRNSTransaction in Own Shares
30th Dec 20245:12 pmRNSTransaction in Own Shares
27th Dec 20244:44 pmRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20243:58 pmRNSTransaction in Own Shares
20th Dec 20244:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.